Last reviewed · How we verify

NCT06654609

Innovation of Custom-made Silicon Insoles for Diabetic Patient

Active, enrolled NA Last updated 23 October 2024
What this trial tests

NA trial testing Insoles for Foot in Diabetic Foot in 4 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
1 November 2023
Primary endpoint
1 June 2024
30 November 2024

Quick facts

Lead sponsorSuperior University
PhaseNA
StatusActive, enrolled
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposesupportive care
Enrollment4
Start date1 November 2023
Primary completion1 June 2024
Estimated completion30 November 2024
Sites1 location across Pakistan

Drugs / interventions tested

Conditions studied

Sponsor

Superior University

Who can join

Adults 30 to 50, any sex, with Diabetic Foot. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

"Diabetic foot ulcers, caused by diabetes-related nerve and blood vessel damage, can lead to amputations. Silicone insoles help prevent ulcers but are often expensive. Affordable, customized insoles are available, making prevention more accessible.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Diabetic Foot

Currently open trials in the same condition.

Other Superior University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06654609.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing